IDH2 and central nervous system cancer: Although previous studies have demonstrated that IDH mutation is sufficient to establish aberrant hypermethylation in glioma [11, 21], the role of these altered methylation states and their relationship with chromatin features in gliomagenesis are not fully understood yet.